Cargando…
Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation
Inflammation is ubiquitous in the body, triggering desirable immune response to defend against dangerous signals or instigating undesirable damage to cells and tissues to cause disease. Nanomedicine holds exciting potential in modulating inflammation. In particular, cell membranes derived from cells...
Autores principales: | Yan, Huize, Shao, Dan, Lao, Yeh‐Hsing, Li, Mingqiang, Hu, Hanze, Leong, Kam W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685500/ https://www.ncbi.nlm.nih.gov/pubmed/31406672 http://dx.doi.org/10.1002/advs.201900605 |
Ejemplares similares
-
Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019) -
A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
por: Hu, Hanze, et al.
Publicado: (2021) -
Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers
por: Dawulieti, Jianati, et al.
Publicado: (2020) -
Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
por: Lee, Na-Hyun, et al.
Publicado: (2022) -
Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)